HIV
Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests
Both tests run on any of the firm's GeneXpert systems and add second targets for HIV detection and early identification.
Altona Diagnostics Nabs CE Mark for HIV-1 Viral Load PCR Assay
The firm's assay leverages reverse transcriptase quantitative PCR to amplify two separate regions of the HIV-1 genome to monitor HIV-infected patients.
Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification
Prequalification from the World Health Organization indicates that products meet high quality standards and are safe for their intended use.
OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate
The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.
Hologic Receives Additional FDA Approval for Diagnostic Use of HIV-1 Viral Load Test
The company said that its Aptima HIV-1 molecular test utilizes a dual-target approach against highly conserved regions in the HIV genome.
May 7, 2020
Grifols ART System Nabs FDA Approval
May 6, 2020
OraSure Technologies Q1 Revenues Rise 5 Percent
Feb 19, 2020
OraSure Technologies Q4 Revenues Down 1 Percent
Jan 30, 2020
Nov 7, 2019
Oct 15, 2019